EPIX : Summary for ESSA Pharma Inc. - Yahoo Finance

U.S. Markets close in 1 hr 59 mins

ESSA Pharma Inc. (EPIX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.29-0.05 (-2.32%)
As of 1:46 PM EST. Market open.
People also watch:
EMISCNCTENZNARQLINSM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.34
Open2.30
Bid2.21 x 1000
Ask2.29 x 200
Day's Range2.29 - 2.30
52 Week Range1.50 - 5.00
Volume6,100
Avg. Volume3,026
Market Cap87.47M
BetaN/A
PE Ratio (TTM)-7.58
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire14 days ago

    ESSA Secures US$10 Million Term Loan from Silicon Valley Bank

    HOUSTON and VANCOUVER, Nov. 21, 2016 /PRNewswire/ - ESSA Pharma Inc. (TSX: EPI, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer, announced that it has secured a US$10 million growth capital term loan facility from Silicon Valley Bank ("SVB" or the "Bank").  Under the loan and security agreement, the Company will initially draw down US$8 million and has a conditional option to receive an additional US$2 million (collectively, the "Term Loans"). The proceeds from the Term Loans will be used for the Company's future working capital needs.

  • CNW Group14 days ago

    ESSA Secures US$10 Million Term Loan from Silicon Valley Bank

    ESSA Secures US$10 Million Term Loan from Silicon Valley Bank

  • CNW Group3 months ago

    ESSA Pharma to present at Rodman & Renshaw 18th Annual Global Investment Conference

    ESSA Pharma to present at Rodman & Renshaw 18th Annual Global Investment Conference